Cirrhosis is the scarring of the liver – hard scar tissue replaces soft healthy tissue. It can take many years for liver damage to lead to cirrhosis. As cirrhosis becomes worse, the liver will have less healthy tissue. If cirrhosis is not treated, the liver will fail and will not be able to work well or at all.
We lay out the basic cirrhosis facts in this infographic.
There are a number of things you can do to maintain the health of your liver. Check out our blog post How to Maintain a Healthy Liver for proactive tips.
If you or a loved one is suffering with cirrhosis, fill out the form below to learn about a cirrhosis clinical research study that’s now enrolling patients.
Treatment Resistant Depression
Treatment Resistant Depression
Low Testosterone and Hypergonadism
Who qualifies for this research study?
Men ages 45-80 with Low Testosterone (hypogonadism) at an increased risk or history of
Cardiovascular Disease. The clinical site will be able to provide more information about additional
requirements for study participation.
Where are the research sites?
There are approximately 400 centers in the United States that are helping to conduct this study.
When will I know if I qualify for a study?
If you pass this initial screener, a member of a study doctor’s staff will contact you – they will ask
you more questions to further assess if you should participate in this study. If they believe that you
should be considered, you will be asked to schedule an appointment at the doctor’s office or clinic
for further evaluations. When you go to the doctor’s office, the study doctor and his/her team
conduct study related examinations and tests to see if you can be enrolled into this study.
How long will my participation in the study last, if I qualify?
Your participation may last for up to approximately 5 years. During this time, the study doctors will
monitor your health and progress.
What is the purpose of these research studies?
The purpose of this study is to evaluate the safety and effectiveness of an investigational
medication for Low Testosterone (hypogonadism) with an increased risk or history of
Cardiovascular Disease.
Low Testosterone or Hypergonadism
Who qualifies for this research study?
Men ages 45-80 with Low Testosterone (hypogonadism) at an increased risk or history of
Cardiovascular Disease. The clinical site will be able to provide more information about additional
requirements for study participation.
Where are the research sites?
There are approximately 400 centers in the United States that are helping to conduct this study.
When will I know if I qualify for a study?
If you pass this initial screener, a member of a study doctor’s staff will contact you – they will ask
you more questions to further assess if you should participate in this study. If they believe that you
should be considered, you will be asked to schedule an appointment at the doctor’s office or clinic
for further evaluations. When you go to the doctor’s office, the study doctor and his/her team
conduct study related examinations and tests to see if you can be enrolled into this study.
How long will my participation in the study last, if I qualify?
Your participation may last for up to approximately 5 years. During this time, the study doctors will
monitor your health and progress.
What is the purpose of these research studies?
The purpose of this study is to evaluate the safety and effectiveness of an investigational
medication for Low Testosterone (hypogonadism) with an increased risk or history of
Cardiovascular Disease.